Citadel Advisors’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $27.8K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $11.5K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $12.5K | Sell |
|
|||||
|
2022
Q4 | $64.4K | Buy |
|
|||||
|
2022
Q3 | $28K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $189K | Sell |
|
|||||
|
2021
Q3 | $321K | Sell |
|
|||||
|
2021
Q2 | $382K | Sell |
|
|||||
|
2021
Q1 | $452K | Buy |
|